Lv11
60 积分 2024-09-12 加入
辅助生殖领域拮抗剂方案标准化应用专家共识
1小时前
待确认
二价HPV疫苗接种策略的卫生经济学评估：基于动态模型
1个月前
已完结
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study
4个月前
已完结
Launois R, Reboul-Marty J, Henry B, et al. A cost-utility analysis of second-line chemotherapy in metastatic breast cancer: Docetaxel versus paclitaxel versus vinorelbine. Pharmacoeconomics (1996) 10: 504-521
5个月前
已完结
One thousand health-related quality-of-life estimates
5个月前
已完结
Cost-effectiveness analysis of pembrolizumab plus chemotherapy for patients with recurrent or metastatic cervical cancer in China
5个月前
已完结
Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA
11个月前
已完结
Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
1年前
已完结
Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA
1年前
已完结
HTA28 A Comparative Review of Pharmacoeconomic (PE) Guidelines in ASIA-Pacific (APAC) with Europe and North America
1年前
已完结
皖公网安备34019202002308
